Analyzing the Effects of Intangible Assets and R\&D Expense on the Financial Statements Selected income statement data for Bristol-Myers Squibb Company and Pfizer, Inc, is presented in the following table: a. Compute the percent of net sales that Bristol-Myers Squibb Company and Pfizer, Inc, spent on research and development (R8D) for years 2018,2019, and 2020. b. Compute the percent of other intangble assets of total assets for Bristol-Myers Squbb Company and pfizer, inc, for years 2018, 2019, and 2020. Compute the percent of net sales that Bristol-Myers Squibb Company and Pfizer, Inc, spent on research and development (R\&.D) for years 2018,2019 , and 2020. b. Compute the percent of other intangible assets of total assets for Bristol:Myers Squibb Company and Plizer, inc, for years 2018,2019, and 2020. . Compute the percent of net sales that Bristol-Myers Squibb Company and Pfizer, Inc, spent on research and development (R\&D) for years 2018,2019 , and 2020. b. Compute the percent of other intangible assets of total assets for Uristol-Myers Squibb Company and Pizer, inc., for years 2018,2019 , and 2020